146 related articles for article (PubMed ID: 38468341)
1. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
Wong P; Wisneski AD; Tsai KK; Chang TT; Hirose K; Nakakura EK; Daud AI; Maker AV; Corvera CU
World J Surg Oncol; 2024 Mar; 22(1):77. PubMed ID: 38468341
[TBL] [Abstract][Full Text] [Related]
2. Use of immunotherapy and surgery for stage IV melanoma.
Molina G; Kasumova GG; Qadan M; Boland GM
Cancer; 2020 Jun; 126(11):2614-2624. PubMed ID: 32157676
[TBL] [Abstract][Full Text] [Related]
3. Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
Medina BD; Choi BH; Rodogiannis KG; Moran U; Shapiro RL; Pavlick A; Osman I; Berman RS; Lee AY
J Surg Oncol; 2020 Sep; 122(3):555-561. PubMed ID: 32441371
[TBL] [Abstract][Full Text] [Related]
4. Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.
Klemen ND; Feingold PL; Goff SL; Hughes MS; Kammula US; Yang JC; Schrump DS; Rosenberg SA; Sherry RM
Ann Surg Oncol; 2017 Jan; 24(1):135-141. PubMed ID: 27638681
[TBL] [Abstract][Full Text] [Related]
5. Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy.
Meacci E; Nachira D; Congedo MT; Ibrahim M; Pariscenti G; Petrella F; Casiraghi M; De Stefani A; Del Regno L; Peris K; Triumbari EKA; Schinzari G; Rossi E; Petracca-Ciavarella L; Vita ML; Chiappetta M; Siciliani A; Peritore V; Manitto M; Morelli L; Zanfrini E; Tabacco D; Calabrese G; Bardoni C; Evangelista J; Spaggiari L; Margaritora S
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173927
[TBL] [Abstract][Full Text] [Related]
6. Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
Bello DM; Panageas KS; Hollmann T; Shoushtari AN; Momtaz P; Chapman PB; Postow MA; Callahan MK; Wolchok JD; Brady MS; Coit DG; Ariyan CE
Ann Surg Oncol; 2020 Apr; 27(4):1180-1188. PubMed ID: 31848819
[TBL] [Abstract][Full Text] [Related]
7. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma.
Li AT; Vakharia K; Lo SN; Varey AHR; Carlino MS; Saw RPM; Shannon KF; Howle JR; Pennington TE; Stretch JR; Nieweg OE; Spillane AJ; Long GV; Menzies AM; Scolyer RA; Thompson JF; Ch'ng S
Ann Surg Oncol; 2021 Oct; 28(11):6109-6123. PubMed ID: 34347220
[TBL] [Abstract][Full Text] [Related]
8. Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication.
He M; Lovell J; Ng BL; Spillane J; Speakman D; Henderson MA; Shackleton M; Gyorki DE
J Surg Oncol; 2015 Jun; 111(8):980-4. PubMed ID: 26080731
[TBL] [Abstract][Full Text] [Related]
9. An unusual presentation of metastatic malignant melanoma causing jejuno-jejunal intussusception: a case report.
Đokić M; Badovinac D; Petrič M; Trotovšek B
J Med Case Rep; 2018 Nov; 12(1):337. PubMed ID: 30419958
[TBL] [Abstract][Full Text] [Related]
10. Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.
Nelson DW; Fischer TD; Graff-Baker AN; Dehal A; Stern S; Bilchik AJ; Faries MB
Ann Surg Oncol; 2019 Dec; 26(13):4610-4618. PubMed ID: 31183639
[TBL] [Abstract][Full Text] [Related]
11. Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series.
Palmer JP; Suriawinata AA; Yan S; Kerr DA; Afzal MZ; Shirai K
Am J Case Rep; 2023 Nov; 24():e938537. PubMed ID: 37978795
[TBL] [Abstract][Full Text] [Related]
12. Surgery for gastrointestinal metastases of malignant melanoma - a retrospective exploratory study.
Holmberg CJ; Alwan G; Ny L; Olofsson Bagge R; Katsarelias D
World J Surg Oncol; 2019 Jul; 17(1):123. PubMed ID: 31299988
[TBL] [Abstract][Full Text] [Related]
13. Role of Surgery in Combination with Immunotherapy.
Klemen ND; Shindorf ML; Sherry RM
Surg Oncol Clin N Am; 2019 Jul; 28(3):481-487. PubMed ID: 31079801
[TBL] [Abstract][Full Text] [Related]
14. Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic Therapy.
Deutsch GB; Flaherty DC; Kirchoff DD; Bailey M; Vitug S; Foshag LJ; Faries MB; Bilchik AJ
JAMA Surg; 2017 Jul; 152(7):672-678. PubMed ID: 28384791
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
16. Current status and novel insights into the role of metastasectomy in the era of immunotherapy.
Liatsou E; Tsilimigras DI; Malandrakis P; Gavriatopoulou M; Ntanasis-Stathopoulos I
Expert Rev Anticancer Ther; 2023 Jan; 23(1):57-66. PubMed ID: 36527305
[TBL] [Abstract][Full Text] [Related]
17. Metastasectomy following incomplete response to high-dose interleukin-2.
Hughes T; Broucek J; Iodice G; Bommareddy PK; Basu S; Kaufman HL
J Surg Oncol; 2018 Mar; 117(4):572-578. PubMed ID: 29165819
[TBL] [Abstract][Full Text] [Related]
18. Thoracic metastasectomy for adoptive immunotherapy of melanoma: a single-institution experience.
Klapper JA; Davis JL; Ripley RT; Smith FO; Nguyen DM; Kwong KF; Mercedes L; Kemp CD; Mathur A; White DE; Dudley ME; Wunderlich JR; Rosenberg SA; Schrump DS
J Thorac Cardiovasc Surg; 2010 Dec; 140(6):1276-82. PubMed ID: 20584535
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma.
Klemen ND; Wang M; Feingold PL; Cooper K; Pavri SN; Han D; Detterbeck FC; Boffa DJ; Khan SA; Olino K; Clune J; Ariyan S; Salem RR; Weiss SA; Kluger HM; Sznol M; Cha C
J Immunother Cancer; 2019 Jul; 7(1):196. PubMed ID: 31340861
[TBL] [Abstract][Full Text] [Related]
20. Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.
Francis JH; Berry D; Abramson DH; Barker CA; Bergstrom C; Demirci H; Engelbert M; Grossniklaus H; Hubbard B; Iacob CE; Jaben K; Kurli M; Postow MA; Wolchok JD; Kim IK; Wells JR
Ophthalmology; 2020 Feb; 127(2):240-248. PubMed ID: 31708274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
